{RIGHTS_NAME} Rights Issue Details

NACL Rights Issue Details

Issue Size (Shares)	32501851	Issue Size (Amount)	-
Issue Price	₹76.70 per share	Face Value	₹1.00 per share
Terms of Payment	The full amount of Rs 76.70 per share will be payable on application.	Listing At	NSE,BSE
Ratio	5:31	Issue Size (₹ Crores)	₹249.29

NACL Industries Limited, a major Indian agrochemical company producing crop protection products like pesticides, fungicides, and herbicides, serving both Indian farmers (domestic retail) and international markets through technical/formulations, is known for its extensive distribution and role as a contract manufacturer, part of the Murugappa Group, focused on sustainable agriculture solutions. The company manufactures technicals (active ingredients) and formulations, catering to domestic farmers and international clients, including major MNCs. The company offers a wide range (over 50) of pesticides, insecticides, fungicides (e.g., Trica), herbicides, and plant growth regulators for various crops. The company has a strong distribution network in India (over 55,000 counters) and exports to over 30 countries.

NACL Rights Issue Timetable

Last Date to buy shares	Thu, Dec 11, 2025	Record Date	Fri, Dec 12, 2025
Credit of Rights Entitlements	Mon, Dec 15, 2025	Bid/Offer Opens On	Mon, Dec 22, 2025
Renunciation of Rights Entitlements	Wed, Dec 24, 2025	Bid/Offer Closes On	Tue, Dec 30, 2025
Deemed Date of Allotment	Wed, Dec 31, 2025	Credit Date	Thu, Jan 01, 2026
Listing Date	Fri, Jan 02, 2026

Company Financials

Nacl Industries Limited's revenue decreased by 30% and profit after tax (PAT) dropped by 56% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended	31 Mar 25	31 Mar 24	31 Mar 23
Assets	1168.64	1668.99	17518.40
Total Income	1261.77	1790.74	21285.50
Profit After Tax	-73.08	-46.96	1377.40
Reserves and Surplus	441.36	506.55	557.53

Amount in ₹ Crore

Objects of the Issue

The company proposes to utilize the Net Proceeds from the Issue towards funding of the following objects:

Repayment and/or prepayment, in full or part, of all or a portion of certain outstanding borrowings availed by our Company, including the interest accrued thereon;
Investment in our wholly owned Subsidiary, NACL Spec-Chem Limited, for repayment/prepayment, in part or full, of certain outstanding borrowings availed by the wholly owned Subsidiary, NACL Spec-Chem Limited, including the interest accrued thereon; and;
General Corporate Purposes.